# Geneos Therapeutics

**Canonical:** https://apis.io/providers/geneos-therapeutics/  
**Website:** https://www.geneostx.com/  
**APIs profiled:** 0

Geneos Therapeutics is a clinical-stage (Phase 2b) biotherapeutics company in Philadelphia, Pennsylvania developing DNA-based personalized immunotherapies for cancer (PICs). Its GT-EPIC neoantigen-targeting platform sequences a patient's tumor, identifies the targetable neoantigens, and encodes up to roughly 40 of them into a synthetic DNA plasmid drug product delivered intradermally alongside a plasmid-encoded IL-12 adjuvant and CELLECTRA electroporation. Geneos was spun out of Inovio Pharmaceuticals and licenses that immunotherapy platform exclusively; it has run clinical work in hepatocellular carcinoma (HCC) and glioblastoma (GBM) and is advancing toward a Phase 2b HCC trial. Geneos is a therapeutics developer, not a software vendor: it publishes no public API, SDK, developer portal or machine-readable contract of any kind.

## Kin Score — 9.6 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0.

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 6.5 |
| Commercial Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Geneos Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Therapeutics, Immunotherapy, Oncology, Precision Medicine, Clinical Stage, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/geneos-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.